340B Insight Podcast
340B Insight is 340B Health’s podcast, providing our members and supporters with timely news updates and discussion around the 340B drug pricing program. The podcast enables listeners to stay current and expand their knowledge of 340B to help them serve their patients and communities and remain compliant with rules and requirements. New episodes are published twice per month and include news update segments and in-depth interviews with leading experts including health care practitioners, policy and legal experts, public policymakers, and our expert staff.
Have a question or suggestion for 340B Insight? Email us at: podcast@340bhealth.org
Podcast sponsorship opportunities are available. Email to learn more: robin.hayes@340bhealth.org
Follow 340B Health on Twitter, Facebook, and LinkedIn
Episodes
-
Episode 63: What the Midterm Election Results Mean for 340B
The recent election results have implications for the future of U.S. health policy and the 340B program. Health policy experts Debbie Curtis and Rodney Whitlock join us this week to discuss how the new Congress will affect 340B and how individuals can best engage in educating and advocating for the program. Debbie and Rodney are vice presidents at McDermott + Consulting and previously were congressional staffers. Before the interview, we provide an update on the litigation process in the 340B contract pharmacy dispute, and we recap HRSA audit results of drug companies. (Transcript)
Read more -
Episode 62: Managing 340B in a Rural Hospital
Nov. 17 is National Rural Health Day, which is an opportunity to celebrate the importance of rural hospitals to patients living in remote communities. We are joined by Karen McCombs, 340B program manager for Wills Memorial Hospital in Georgia. Karen shares her tips for managing her critical access hospital’s 340B program in a compliant and efficient manner to support patient care initiatives. Before the interview, we provide updates on the 2023 Medicare payment rate for 340B drugs and on the status of 340B contract pharmacy litigation pending in federal appeals courts. (Transcript)
Read more -
Episode 61: Congressman Henry Waxman Reflects on 30 Years of 340B
On Nov. 4, 1992, President George H.W. Bush signed the 340B drug pricing program into law. To celebrate 30 years of 340B, we speak on today’s episode with former Congressman Henry Waxman, who was one of the principal architects of the 340B program. Congressman Waxman served in Congress for 40 years from 1975-2015. During part of that time, he chaired the influential U.S. House Energy & Commerce Committee and U.S. House Government & Oversight Committee.
Chairman Waxman shares why Congress created 340B, explains the need for a strong health care safety net, discusses 340B’s achievements, and remarks on why the program is just as important today as it was 30 years ago. (Transcript).
Read more -
Episode 60: Moving Patients from Emergency Care to Coordinated Care
When Hennepin Medical Center saw that some of their patients were frequently visiting the emergency department for all their health care needs, they recognized how vital it was to find a better way to care for them. Our guest this week is Christene Jolowsky, senior director of pharmacy at Hennepin Healthcare. Christene shares how Hennepin has used 340B savings to operate a coordinated care clinic that meets the health and social needs of their patients. Prior to the interview, we provide news updates on the restoration of full Medicare payment rates for 340B drugs and details about another drug company that is attempting to block the federal government from requiring 340B discounts on drugs dispensed at contract pharmacies. (Transcript)
Read more -
Episode 59: A 30-Year Perspective on 340B
All this year we are reflecting on the approaching 30th anniversary of the 340B program and celebrating the patient care successes the program has enabled over the past three decades. This week, we are joined by Andrew Lowe, clinical director of pharmacy at Arrowhead Regional Medical Center in California. Arrowhead has participated in 340B since the first days that hospitals were eligible for the program. Andy has had a front-row seat the entire time to see the difference 340B has made in the lives of patients in need and the health care safety net’s ability to care for them. He shares how Arrowhead navigated health care in a pre-340B world and what the program has allowed his hospital to accomplish in patient care over the past 30 years. Prior to the interview, we share several news updates on new developments on Medicare cuts for 340B drugs, the release of new 340B research, and more. (Transcript)
Read more -
Episode 58: Maureen Testoni Analyzes Recent 340B Developments
It has been an eventful summer for 340B, and we are checking in this week with 340B Health President and CEO Maureen Testoni to hear her analysis on the top 340B developments. Maureen provides updates on issues that include the contract pharmacy dispute, Medicare payment cuts, and the new drug pricing law. She also shares a preview of what may occur in the fall. (Transcript)
Read more